![CRB Monitor - Cannabis-Related Equity Performance - December 2023](https://news.crbmonitor.com/wp-content/uploads/2024/02/Cannabis-related-equity-performance-png-Jan-19-2024-03-21-39-8462-PM.png-e1707249452470.webp)
Cannabis-Related Securities | Monthly Update | December 2023
December 2023 provided, if nothing else, a ray of hope for those investors that have stuck around for the duration of this performance history that boasts all t... Read more.
![CRB Monitor - Cannabis-Related Equity Performance - November 2023](https://news.crbmonitor.com/wp-content/uploads/2023/12/image-png-Dec-21-2023-04-10-43-6111-PM.png.webp)
Cannabis-Related Securities | Monthly Update | November 2023
November 2023 had cannabis investors saying, “Well, at least it didn’t tank again”. In fact, they were treated to returns that reflected either 1) optimis... Read more.
![CRB Monitor - Cannabis-Related Equity Performance](https://news.crbmonitor.com/wp-content/uploads/2023/11/image-png-Nov-20-2023-03-04-00-9970-PM.png-e1700605285872.webp)
Cannabis-Related Securities | Monthly Update | October 2023
October 2023 saw precious little support for cannabis equities (see above), and many CRBs returned to their pre-HHS rescheduling announcement lows. We are all o... Read more.
![CRB Monitor Chart of the Month - October 2023 - Cannabis-Related Equity Performance](https://news.crbmonitor.com/wp-content/uploads/2023/11/image-png-Oct-23-2023-09-52-50-8470-AM-e1698861743196.png)
Cannabis-Related Securities Quarterly Update | Third Quarter 2023
The CRB Monitor Securities Research team covers all aspects of the publicly-traded cannabis ecosystem, including the regulatory environment, operational expansi... Read more.
![CRBMonitor - Cannabis-Related Equity Performance - September 2023](https://news.crbmonitor.com/wp-content/uploads/2023/11/image-png-Oct-17-2023-07-28-59-5275-PM-e1698864914972.webp)
Cannabis-Related Securities Monthly Update | September 2023
With the hysteria over The announcement that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule III from Schedule I no... Read more.
![](https://news.crbmonitor.com/wp-content/uploads/2023/10/DollarLeaf-thumbnail.png)
CRB Monitor Chart of the Month | September 2023
This month we take a closer look at the near-term health of the largest 20 pure play Tier 1 CRBs, as we consider what investors have to look forward to given th... Read more.